You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Dr Reddys La Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for DR REDDYS LA, and what generic and branded alternatives to DR REDDYS LA drugs are available?

DR REDDYS LA has one hundred and ninety-six approved drugs.

There are twenty-two tentative approvals on DR REDDYS LA drugs.

Summary for Dr Reddys La
US Patents:0
Tradenames:161
Ingredients:141
NDAs:196

Drugs and US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa TRIVORA-21 ethinyl estradiol; levonorgestrel TABLET;ORAL-21 074538-001 Dec 18, 1997 DISCN No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Sa METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE metformin hydrochloride; saxagliptin hydrochloride TABLET, EXTENDED RELEASE;ORAL 207678-001 Aug 9, 2023 AB RX No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Ltd LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 090392-001 Feb 24, 2011 AB RX No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Ltd LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 202383-004 Jun 19, 2013 AB RX No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Sa OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091313-002 Feb 18, 2011 DISCN No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Sa NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate CAPSULE;ORAL 213901-001 Apr 28, 2022 DISCN No No ⤷  Subscribe ⤷  Subscribe
Dr Reddys Labs Ltd CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 091023-001 May 17, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa TRI-NORINYL 21-DAY ethinyl estradiol; norethindrone TABLET;ORAL-21 018977-001 Apr 13, 1984 4,390,531 ⤷  Subscribe
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,016,652 ⤷  Subscribe
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,834,011 ⤷  Subscribe
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ⤷  Subscribe
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ⤷  Subscribe
Dr Reddys Labs Sa TRI-NORINYL 28-DAY ethinyl estradiol; norethindrone TABLET;ORAL-28 018977-002 Apr 13, 1984 4,390,531 ⤷  Subscribe
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for DR REDDYS LA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.